Invests in
Locations:
Min Investment:
$250,000.00Max Investment:
$750,000.00Target Investment:
$500,000.00
Skills
Education
Lists including Phil
Investments
Work Experience
2002
Co-Founder and Managing Partner
2002
Early-stage healthcare venture capital firm, with a focus on life science platforms, digital health, and animal health opportunities.
2014
Board Director and Investor
2014
Antibody therapeutics to treat cancer (Nasdaq: CMPX)
2021
Board Director and Investor
2021
Intratumoral immunotherapy.
2020
Investor and Former Board Director
2020
Genetics-informed antibody therapies for I&I disorders.
2019
Board Director and Investor
2019
Redefining the role of genomic laboratories in delivering better healthcare.
2020
Investor and Former Board Director
2020
Platform company developing novel TCR therapies for cancer and autoimmune disease.
2018
Board Director and Investor
2018
Peptide discovery platform company spun out from the University of Oxford
2018
Board Observer and Investor
2018
The future of clinical research.
2008
Investor
2008
Premier human antibody discovery and humanization.
2018
Investor
2018
Transformative exosome therapeutics.